Bajaj Healthcare Limited (BHL), a leading manufacturer of Active Pharmaceutical Ingredients (APIs) and finished formulations, has announced the re-appointment of Mr. Anil Champalal Jain as its Managing Director. His new term is set to commence on April 1, 2026. Mr. Jain has been a pivotal figure in the company’s growth, steering its expansion into specialized chemical segments and strengthening its manufacturing infrastructure. This re-appointment ensures continuity in leadership as the company targets higher growth in domestic and international pharmaceutical markets.
